MAPT and Alzheimer disease: This is consistent with several studies demonstrating the onset of tau pathological accumulation after widespread amyloid plaque accumulation but prior to clinical diagnosis observed in preclinical AD (Bloom, 2014;Gulisano et al., 2018).